Involved field radiation therapy following high dose chemotherapy and autologous stem cell transplant benefits local control and survival in refractory or recurrent Hodgkin lymphoma.

@article{Biswas2012InvolvedFR,
  title={Involved field radiation therapy following high dose chemotherapy and autologous stem cell transplant benefits local control and survival in refractory or recurrent Hodgkin lymphoma.},
  author={Tithi Biswas and Eva Culakova and Jonathan W. Friedberg and Jennifer Lynn Kelly and Sughosh Dhakal and Jane L Liesveld and Gail Lewis Phillips and Louis Sandy Constine},
  journal={Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology},
  year={2012},
  volume={103 3},
  pages={
          367-72
        }
}
BACKGROUND AND PURPOSE Patients with recurrent or primary refractory Hodgkin lymphoma (HL) treated with high dose chemotherapy (HDT) and autologous stem cell transplant (ASCT) commonly relapse post-ASCT in previous disease sites. We sought to evaluate involved field radiation therapy (IFRT) following ASCT and patterns of recurrence, overall survival (OS), and disease specific survival (DSS). METHODS AND MATERIALS Between May 1993 and October 2003, 62 (n=66) evaluable patients with refractory… CONTINUE READING
BETA
1
Twitter Mention

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 10 CITATIONS

SEOM clinical guidelines for the treatment of Hodgkin’s lymphoma

  • Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
  • 2010
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 22 REFERENCES

Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2009
VIEW 1 EXCERPT

Long-term effects of high-dose chemotherapy and radiation for relapsed and refractory Hodgkin's lymphoma.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2008
VIEW 1 EXCERPT

Epidemiology of Hodgkin's disease and non-Hodgkin's lymphoma

  • European Journal of Nuclear Medicine and Molecular Imaging
  • 2003
VIEW 1 EXCERPT